Trade Pliant Therapeutics, Inc. - PLRX CFD

Trading Conditions

• Type: CFD
• Spread: 0.05
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 1.38
• Open: 1.36
• 1-Year Change: -11.11%
• Day's Range: 1.29 - 1.36

What is Pliant Therapeutics, Inc. (PLRX)?

Pliant Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing therapies targeting fibrotic diseases. The company employs a precision medicine approach to identify and inhibit key biological pathways involved in fibrosis across various organs. Pliant's pipeline includes product candidates aimed at treating conditions such as liver fibrosis, pulmonary fibrosis, and other fibrotic disorders. The company advances its candidates through preclinical and clinical development stages, emphasizing translational science and biomarker-driven strategies. Headquartered in Redwood City, California, Pliant Therapeutics collaborates with research institutions and industry partners to develop innovative treatments addressing significant unmet medical needs.

Pliant Therapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by current market movements, with Pliant Therapeutics, Inc. at $1.38. It has moved within a range of $1.29 to $1.41, reflecting a daily change of 0%.

FAQ: Pliant Therapeutics, Inc. (PLRX)

What is the current price of PLRX stock?

The current trading price is $1.38.

Does PLRX pay dividends?

Pliant Therapeutics, Inc. does not pay dividends.

Does PLRX have a formal corporate presence or regional headquarters in the UAE?

Pliant Therapeutics, Inc. has no official regional office or subsidiary in the UAE and operates through distributors.

What is PLRX best known for?

Pliant Therapeutics, Inc. is most famous for its development of fibrosis-targeting therapies.

What assets are typically shown together with PLRX?

Commonly shown alongside PLRX: Shionogi & Co., Ltd., Repligen Corp, Abbott